Skip to main content

Acadia Pharmaceuticals Inc

ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001070494

In the last 90 days, Acadia Pharmaceuticals Inc insiders filed 0 open-market purchases and 2 sales; 353 institutions reported holding it in 13F filings for Q2 2026, worth $4.27B in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in Acadia Pharmaceuticals Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
228
+7 vs. Q3 2022
Shares held
155.8M
+3.39M (+2.2%) vs. Q3 2022
Total value
$2.48B
−$13.0M (−0.5%) vs. Q3 2022
New holders
30
73 more added
Sold out
23
81 more reduced

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACAD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 228 institutions
Q1 2021: 272 institutionsQ2 2021: 245 institutionsQ3 2021: 238 institutionsQ4 2021: 247 institutionsQ1 2022: 262 institutionsQ2 2022: 246 institutionsQ3 2022: 223 institutionsQ4 2022: 228 institutionsQ1 2023: 234 institutionsQ2 2023: 236 institutionsQ3 2023: 249 institutionsQ4 2023: 277 institutionsQ1 2024: 268 institutionsQ2 2024: 265 institutionsQ3 2024: 258 institutionsQ4 2024: 296 institutionsQ1 2025: 320 institutionsQ2 2025: 311 institutionsQ3 2025: 334 institutionsQ4 2025: 336 institutionsQ1 2026: 343 institutionsQ2 2026: 353 institutions
Value heldQ4 2022: $2.48B
Q1 2021: $3.76BQ2 2021: $3.61BQ3 2021: $2.41BQ4 2021: $3.46BQ1 2022: $3.56BQ2 2022: $2.13BQ3 2022: $2.49BQ4 2022: $2.48BQ1 2023: $2.97BQ2 2023: $3.81BQ3 2023: $3.25BQ4 2023: $4.99BQ1 2024: $2.99BQ2 2024: $2.62BQ3 2024: $2.41BQ4 2024: $2.99BQ1 2025: $2.87BQ2 2025: $3.66BQ3 2025: $3.58BQ4 2025: $4.44BQ1 2026: $3.67BQ2 2026: $4.27B
Institutions holding ACAD and their total value by quarter
QuarterHoldersValue
Q2 2026353$4.27B
Q1 2026343$3.67B
Q4 2025336$4.44B
Q3 2025334$3.58B
Q2 2025311$3.66B
Q1 2025320$2.87B
Q4 2024296$2.99B
Q3 2024258$2.41B
Q2 2024265$2.62B
Q1 2024268$2.99B
Q4 2023277$4.99B
Q3 2023249$3.25B
Q2 2023236$3.81B
Q1 2023234$2.97B
Q4 2022228$2.48B
Q3 2022223$2.49B
Q2 2022246$2.13B
Q1 2022262$3.56B
Q4 2021247$3.46B
Q3 2021238$2.41B
Q2 2021245$3.61B
Q1 2021272$3.76B

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Acadia Pharmaceuticals Inc; share changes are against Q3 2022.

Institutions holding ACAD in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Goldman Sachs Group Inc990,623$15.8M0.00%−189,775−16.1%Reduced
Healthcare of Ontario Pension Plan Trust Fund1,029,400$16.4M0.08%+154,100+17.6%Added
Emerald Mutual Fund Advisers Trust1,048,750$16.7M1.03%+16,011+1.6%Added
Jupiter Asset Management Ltd1,089,972$17.3M0.25%+1,012,680+1,310.2%Added
Point72 Asset Management, L.P.1,115,900$17.8M0.07%+1,115,900New
Northern Trust Corp1,127,284$17.9M0.00%+10,345+0.9%Added
Finepoint Capital LP1,176,830$18.7M6.06%+65,800+5.9%Added
Millennium Management LLC1,202,329$19.1M0.02%+833,651+226.1%Added
Emerald Advisers, LLC1,322,146$21.0M1.02%−7,480−0.6%Reduced
Fred Alger Management, LLC1,462,654$23.3M0.13%−74,180−4.8%Reduced
Braidwell LP1,493,121$23.8M0.80%+1,493,121New
Wellington Management Group LLP1,579,910$25.2M0.01%−132,877−7.8%Reduced
Jacobs Levy Equity Management, Inc1,639,183$26.1M0.18%+552,681+50.9%Added
Norges Bank1,954,156$31.1M0.01%−23,000−1.2%Reduced
JPMorgan Chase & Co2,095,491$33.4M0.00%+236,530+12.7%Added
Geode Capital Management, LLC2,299,499$36.6M0.01%+78,348+3.5%Added
Palo Alto Investors LP2,376,369$37.8M3.23%+698,173+41.6%Added
Morgan Stanley2,744,738$43.7M0.00%−326,375−10.6%Reduced
First Trust Advisors LP2,882,361$45.9M0.05%−37,499−1.3%Reduced
RTW Investments, LP3,670,938$58.4M1.19%00.0%Unchanged
D. E. Shaw & Co., Inc.4,219,399$67.2M0.11%−492,781−10.5%Reduced
Price T Rowe Associates Inc4,279,254$68.1M0.01%−612,094−12.5%Reduced
EcoR1 Capital, LLC5,991,479$95.4M2.91%00.0%Unchanged
State Street Corp7,740,338$123.2M0.01%+961,467+14.2%Added
FMR LLC9,334,614$148.6M0.01%−2,236,411−19.3%Reduced
BlackRock Inc.10,259,184$163.3M0.01%+286,029+2.9%Added
Vanguard Group Inc13,279,775$211.4M0.01%+354,134+2.7%Added
Baker Bros. Advisors LP41,923,486$667.4M4.01%00.0%Unchanged
Boxer Capital, LLC0$00.00%−1,263,930−100.0%Sold out
Fairmount Funds Management LLC0$00.00%−751,804−100.0%Sold out
Squarepoint Ops LLC0$00.00%−475,921−100.0%Sold out
Woodline Partners LP0$00.00%−395,549−100.0%Sold out
UBS Asset Management Americas Inc0$00.00%−123,201−100.0%Sold out
Susquehanna Fundamental Investments, LLC0$00.00%−70,900−100.0%Sold out
AlphaCrest Capital Management LLC0$00.00%−35,044−100.0%Sold out
Crown Advisors Management, Inc.0$00.00%−30,000−100.0%Sold out
Seven Eight Capital, LP0$00.00%−26,935−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−21,618−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−17,800−100.0%Sold out
Prudential Financial Inc0$00.00%−17,296−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−14,920−100.0%Sold out
Creative Planning0$00.00%−13,202−100.0%Sold out
Jump Financial, LLC0$00.00%−13,100−100.0%Sold out
Lazard Asset Management LLC0$00.00%−3,689−100.0%Sold out
Allworth Financial LP0$00.00%−820−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−435−100.0%Sold out
Bartlett & Co. LLC0$00.00%−100−100.0%Sold out
Prestige Wealth Management Group LLC0$00.00%−100−100.0%Sold out
Bartlett & Co. Wealth Management LLC0$00.00%−100−100.0%Sold out
Howe & Rusling Inc0$00.00%−54−100.0%Sold out
Signaturefd, LLC0$00.00%−20−100.0%Sold out
Wipfli Financial Advisors LLC,––––Not filed
American Research & Management Co.––––Not filed